ISS Research: Space-Grown Stem Cells Could Transform Blood Cancer Treatments
NASA-backed research aims to overcome Earth-based production limits, potentially offering more reliable therapies for leukemia and severe immune diseases
Astronauts aboard the International Space Station are conducting the InSPA-StemCellEX-H2 investigation to manufacture large quantities of high-quality blood stem cells in microgravity. Led by Dr Tobias Niederwieser, assistant research professor at BioServe Space Technologies within the University of Colorado Boulder, the study seeks to address significant limitations in Earth-based stem cell production. The research aims to create reliable, long-term cell supplies for treating leukemia, blood cancers, and severe immune diseases on Earth.
Stem cells derived from the human body are expanded in laboratories to produce large quantities of cells for patient use. While this process can be performed on Earth, the cells often lose their ability to form critical blood components such as red and white blood cells and platelets. This limitation is particularly problematic for leukemia patients who require stem cells to rebuild their blood systems following chemotherapy.
Previous studies focused on fine-tuning the hardware used to produce greater quantities of high-quality stem cells. The current phase of the InSPA-StemCellEX-H2 investigation shifts focus to demonstrating large-scale production capabilities for pharmaceutical and clinical use. Dr Niederwieser states that the microgravity environment is more suitable for keeping stem cells in a high-quality state during expansion.
Scientists predict that growing cells in space may lead to higher expansion potential and a lower risk of rejection when these cells are used in patients on Earth. This prediction remains an experimental aim rather than a confirmed clinical outcome, as the research is currently in the phase of demonstrating production capabilities.
The end result of this work is to benefit patients in hospitals on Earth by enabling more reliable and accessible therapies. Space station research allows scientists and commercial companies globally to test new technologies and innovative medical solutions with the potential to greatly benefit life on Earth.
